BETA-LACTAMASE EXPRESSION AND CROSS-RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN A NOSOCOMIAL POPULATION OF ENTEROBACTER

被引:5
|
作者
STEFFEE, CH
WASILAUSKAS, BL
机构
[1] Department of Pathology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC
关键词
BETA-LACTAMASE; ENTEROBACTER-CLOACAE; ENTEROBACTER-AEROGENES;
D O I
10.1159/000239016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study sought to quantitatively describe the spectrum of constitutive and inducible beta-lactamase activity present in a tertiary care center's population of Enterobacter species. Beta-Lactamase activity in the absence and presence of 2 recognized beta-lactamase-inducing antibiotics, cefoxitin and imipenem, was measured. The Enterobacter cloacae (n = 35) population was strikingly bimodal, expressing 'all-or-none' cross-resistance to beta-lactams (except imipenem) corresponding to the baseline level of beta-lactamase expression. E. aerogenes (n = 14) displayed a less dichotomous pattern of resistance, and MICs of beta-lactam antibiotics were less strongly related to the magnitude of enzyme activity. We conclude that our nosocomial population of E. cloacae, like strains rendered resistant to beta-lactams in vitro, is largely dependent upon beta-lactamase as a mechanism of this resistance. Furthermore, we document the presence of a large subpopulation of beta-lactam-susceptible isolates possessing inducible beta-lactamase and therefore subject to selection for enzyme derepression.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 50 条
  • [31] MUTATIONAL ENZYMATIC RESISTANCE OF ENTEROBACTER SPECIES TO BETA-LACTAM ANTIBIOTICS
    LAMPE, MF
    ALLAN, BJ
    MINSHEW, BH
    SHERRIS, JC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) : 655 - 660
  • [32] THE CONTRIBUTION OF BETA-LACTAMASE STABILITY TO THE DESIGN OF BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS
    SIMPSON, IN
    HARPER, PB
    JOURNAL OF APPLIED BACTERIOLOGY, 1984, 57 (03): : R7 - R7
  • [33] Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations
    Stephanie Ho
    Lynn Nguyen
    Trang Trinh
    Conan MacDougall
    Current Infectious Disease Reports, 2019, 21
  • [34] THE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF CEFPIRAMIDE COMPARED WITH OTHER BETA-LACTAM ANTIBIOTICS
    NEU, HC
    CHIN, NX
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1985, 3 (06) : 479 - 488
  • [35] Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations
    Ho, Stephanie
    Lynn Nguyen
    Trang Trinh
    MacDougall, Conan
    CURRENT INFECTIOUS DISEASE REPORTS, 2019, 21 (10)
  • [36] ROLES OF PORIN AND BETA-LACTAMASE IN BETA-LACTAM RESISTANCE OF PSEUDOMONAS-AERUGINOSA
    HANCOCK, REW
    WOODRUFF, WA
    REVIEWS OF INFECTIOUS DISEASES, 1988, 10 (04): : 770 - 775
  • [37] ROLE OF THE BETA-LACTAMASE OF CAMPYLOBACTER-JEJUNI IN RESISTANCE TO BETA-LACTAM AGENTS
    LACHANCE, N
    GAUDREAU, C
    LAMOTHE, F
    LARIVIERE, LA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) : 813 - 818
  • [38] NOVEL BETA-LACTAMASE IN A CLINICAL ISOLATE OF KLEBSIELLA-PNEUMONIAE CONFERRING UNUSUAL RESISTANCE TO BETA-LACTAM ANTIBIOTICS
    SPENCER, RC
    WHEAT, PF
    WINSTANLEY, TG
    COX, DM
    PLESTED, SJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (06) : 919 - 921
  • [39] EFFECT OF BETA-LACTAMASE EXPRESSION ON SUSCEPTIBILITY OF LOCAL ISOLATES OF ENTEROBACTER-CLOACAE, SERRATIA-MARCESCENS AND PSEUDOMONAS-AERUGINOSA TO BETA-LACTAM ANTIBIOTICS
    RAMADAN, MA
    TAWFIK, AF
    SHIBL, AM
    CHEMOTHERAPY, 1995, 41 (03) : 193 - 199
  • [40] STRUCTURAL CHARACTERIZATION OF BETA-LACTAMASE INACTIVATED BY BETA-LACTAM SULFONES
    ELLERBY, LM
    FINK, AL
    HSIEH, M
    BIOPHYSICAL JOURNAL, 1987, 51 (02) : A312 - A312